Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer

por Tanese, Keiji, Nakamura, Yoshio, Hirai, Ikuko, Funakoshi, Takeru
Publicado 2019

New Therapy Using Omega-3-Acid Ethyl Esters for Decubitus Ulcers and Stasis Dermatitis: A Case Report

por Nagai, Kazuki, Matsumaru, Katsuhiko, Hirai, Ikuko, Takae, Yujiro, Andoh, Kazuo
Publicado 2014

Cutaneous Inflammatory Pseudotumour of the Face; Does this Almost Forgotten Disease Concept Still Exist?

por Matsuzaki, Hitomi, Hirai, Ikuko, Tamura, Kana, Yamanishi, Ayumi, Wada, Mai, Kawashima, Yuhei, Tanikawa, Akiko, Tanese, Keiji
Publicado 2023

Imatinib mesylate in combination with pembrolizumab in patients with advanced KIT-mutant melanoma following progression on standard therapy: A phase I/II trial and study protocol

por Hirai, Ikuko, Tanese, Keiji, Fukuda, Keitaro, Fusumae, Takayuki, Nakamura, Yoshio, Sato, Yasunori, Amagai, Masayuki, Funakoshi, Takeru
Publicado 2021

Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study)

por Ishii, Maki, Hirai, Ikuko, Tanese, Keiji, Fusumae, Takayuki, Nakamura, Yoshio, Fukuda, Keitaro, Uchi, Hiroshi, Kabashima, Kenji, Otsuka, Atsushi, Yokota, Kenji, Yamazaki, Naoya, Namikawa, Kenjiro, Fujimura, Taku, Takenouchi, Tatsuya, Yamamoto, Yuki, Nishiguchi, Mana, Sato, Yasunori, Amagai, Masayuki, Funakoshi, Takeru
Publicado 2020

Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors

por Hirai, Ikuko, Funakoshi, Takeru, Kamijuku, Hajime, Fukuda, Keitaro, Mori, Mariko, Sakurai, Masatoshi, Koda, Yuya, Kato, Jun, Mori, Takehiko, Watanabe, Naohide, Noji, Shinobu, Yaguchi, Tomonori, Iwata, Takashi, Ohta, Shigeki, Fujita, Tomonobu, Tanosaki, Ryuji, Handa, Makoto, Okamoto, Shinichiro, Amagai, Masayuki, Kawakami, Yutaka
Publicado 2021